SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Sustainability of KPLHS through capacity building platform- Rangsima Airawanwat, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018KPLHS for same-day ART and differentiated service delivery in Thailand- Chamrong PhaengnongyangView Slideset
TLThuy LeMD, DPhilSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Con debater: IPT should be implemented for all HIV patientsin the Asia-Pacific- Thuy Le, MD, DPhilView Slideset
MBMark BoydBA, BM, BS, DCTH&H, MHID, MD, FRACPSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Pro debater: IPT should be implemented for all HIV patients in the Asia-Pacific- Mark Boyd, BA, BM, BS, DCTH&H, MHID, MD, FRACPView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Renal and liver function changes among post-exposure prophylaxis clients at the Thai Red Cross Anonymous Clinic in Bangkok- Samanan ThongyoiView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Changes in creatinine and estimated glomerular filtration rate during the first 12-month period of pre-exposure prophylaxis among PrEP-30 clients at the Thai Red Cross anonymous clinic- Piyanuch TuntikulView Slideset
YHYi-Chia HuangMDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Feasibility and outcome of rapid initiation of antiretroviral treatment among newly-diagnosed HIV-positive patients at a tertiary center in Taiwan- Yi-Chia HuangView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan- Wang-Da LiuView Slideset
RRReena RajasuriarMPharm, PhDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Addressing long-term complications to improve health outcomes in HIV- Reena Rajasuriar, MPharm, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Social media platforms for LGBT inclusion- Laurindo GarciaView Slideset
KRKiat RuxrungthamMDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Improving tolerability by optimizing ART- Kiat Ruxrungtham, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Optimal timing of antiretroviral therapy for HIV-infected patients with cryptococcal meningitis: A systematic review and meta-analysis- Yaokai ChenView Slideset
